Lung Cancer

Conference Coverage

Greater Immune Protection Against SARS-CoV-2 Needed in Lung Cancer Therapy

09/10/2021

An ongoing cohort study found that although most lung cancer patients have displayed promising antibody responses to SARS-CoV-2 vaccinations, a subgroup exhibited significantly lower antibody/neutralizing levels, indicating further studies...

An ongoing cohort study found...

09/10/2021

Oncology

News

Selpercatinib Superior to Prior Systemic Therapy in RET-Positive NSCLC

06/22/2021

Patients with RET-positive NSCLC who received selpercatinib therapy had a better overall response than those who received prior systemic therapy, according to findings from the phase 1/2 LIBRETTO-001 trial.

Patients with RET-positive NSCLC...

06/22/2021

Oncology

News

Sotorasib Safe, Effective for KRAS p.G12C-mutated NSCLC

06/10/2021

Sotorasib therapy demonstrated durable efficacy with manageable safety for previously treated KRAS p.G12C-mutated NSCLC.

Sotorasib therapy demonstrated...

06/10/2021

Oncology

Videos

Dr Bruno Highlights Racial Disparities in Testing, Trial Enrollment in NSCLC

06/07/2021

Dr Bruno, MD, discusses the racial disparities in biomarker testing and clinical trial enrollment in patients with NSCLC.

Dr Bruno, MD, discusses the...

06/07/2021

Oncology

Videos

Ongoing Trial Will Assess Trastuzumab Deruxtecan–Pembrolizumab Combo for Breast Cancer, NSCLC

05/27/2020

Hope Rugo, MD, looks forward to the safety and efficacy findings of an ongoing study examining trastuzumab deruxtecan plus pembrolizumab for breast cancer and NSCLC.

Hope Rugo, MD, looks forward to...

05/27/2020

Oncology